69. Gaber AO, Shokouh-Amiri H, Grewal HP, et al. A technique for portal pancreatic transplantation

with enteric drainage. Surg Gynecol Obstet 1993;177:417–419.

70. Sollinger HW, Sasaki TM, D’Alessandro AM, et al. Indications for enteric conversion after pancreas

transplantation with bladder drainage. Surgery 1992;112:842–846.

71. Benedetti E, Najarian JS, Gruessner AC, et al. Correlation between cystoscopic biopsy results and

hypoamylasuria in bladder-drained pancreas transplants. Surgery 1995;118:864–872.

72. Adrogue HE, Matas AJ, McGlennon RC, et al. Do inherited hypercoagulable states play a role in

thrombotic events affecting kidney/pancreas transplant recipients? Clin Transplant 2007:21:32–37.

73. Troppmann C, Gruessner AC, Dunn DL, et al. Surgical complications requiring early relaparotomy

after pancreas transplantation: a multivariate risk factor and economic impact analysis of the

cyclosporine era. Ann Surg 1998;227:255–268.

74. Stratta RJ, Alloway RR, Lo A, et al. Two-dose daclizumab regimen in simultaneous kidney-pancreas

transplant recipients: primary endpoint analysis of a multicenter, randomized study. Transplantation

2003;75:1260–1266.

75. Kaufman DB, Iii GW, Bruce DS, et al. Prospective, randomized, multi-center trial of antibody

induction therapy in simultaneous pancreas-kidney transplantation. Am J Transplant 2003;3:855–

864.

76. Freise CE, Kang SM, Feng S, et al. Excellent short-term results with steroid-free maintenance

immunosuppression in low-risk simultaneous pancreas-kidney transplantation. Arch Surg

2003;138:1121–1126.

77. Kaufman DB, Leventhal JR, Koffron AJ, et al. A prospective study of rapid corticosteroid

elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance

immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

Transplantation 2002;73:169–177.

1006

78. Kaufman DB, Leventhal JR, Gallon LG, et al. Alemtuzumab induction and prednisone-free

maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with

rabbit antithymocyte globulin induction – long-term results. Am J Transplant 2006;6:331–339.

79. Thai NL, Khan A, Tom K, et al. Alemtuzumab induction and tacrolimus monotherapy in pancreas

transplantation: one- and two-year outcomes. Transplantation 2006;82:1621–1624.

80. Troppmann C, Gruessner AC, Benedetti E, et al. Vascular graft thrombosis after pancreatic

transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am

Coll Surg 1996;182:285–316.

81. Finger EB, Radosevich DM, Dunn TB, et al. A composite risk model for predicting technical failure

in pancreas transplantation. Am J Transplant 2013;13(7):1840–9.

82. Gilabert R, Fernandez-Cruz L, Real MI, et al. Treatment and outcome of pancreatic venous graft

thrombosis after kidney-pancreas transplantation. Br J Surg 2002;89:355–360.

83. Ciancio G, Julian JF, Fernandez L, et al. Successful surgical salvage of pancreas allografts after

complete venous thrombosis. Transplantation 2000;70:126–131.

84. Kim YH, Park JB, Lee SS, et al. How to avoid graft thrombosis requiring graftectomy: immediate

posttransplant CT angiography in pancreas transplantation. Transplantation 2012;94(9):925–930.

85. Garcia-Roca R, Samame J, Garcia-Criado MA. et al. Preservation of pancreas graft function after

complete venous thrombosis: report of four cases treated conservatively. Transplantation

2012;93(2):214–218.

86. Scheffert JL, Taber DJ, Pilch NA, et al. Clinical outcomes associated with the early postoperative

use of heparin in pancreas transplantation. Transplantation 2014;97(6):681–685.

87. Sollinger HW, Odorico JS, Knechtle SJ, et al. Experience with 500 simultaneous pancreas-kidney

transplants. Ann Surg 1998;228:284–296.

88. Nath DS, Gruessner A, Kandaswamy R, et al. Late anastomotic leaks in pancreas transplant

recipients – clinical characteristics and predisposing factors. Clin Transplant 2005:19:220–224.

89. Niederhaus SV, Leverson GE, Lorentzen DF, et al. Acute cellular and antibody-mediated rejection of

the pancreas allograft: incidence, risk factors and outcomes. Am J Transplant 2013;13(11):2945–

2955.

90. Cantarovich D, De Amicis S, Akl A, et al. Posttransplant donor-specific anti-HLA antibodies

negatively impact pancreas transplantation outcome. Am J Transplant 2011;11(12):2737–2746.

91. Kersting S, Ludwig S, Ehehalt F, et al. Contrast-enhanced ultrasonography in pancreas

transplantation. Transplantation 2013;95(1):209–214.

92. Kuo PC, Johnson LB, Schweitzer EJ, et al. Solitary pancreas allografts. The role of percutaneous

biopsy and standardized histologic grading of rejection. Arch Surg 1997;132(1):52–57.

93. Bartlett ST, Schweitzer EJ, Johnson LB, et al. Equivalent success of simultaneous pancreas kidney

and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with

percutaneous biopsy. Ann Surg 1996;224:440–452.

94. Sutherland DER, Gruessner RWG, Dunn DL, et al. Lessons learned from more than 1,000 pancreas

transplants at a single institution. Ann Surg 2001;233(4):463–501.

95. Carpenter HA, Engen DE, Munn SR, et al. Histologic diagnosis of rejection by using cystoscopically

directed needle biopsy specimens from dysfunctional pancreatoduodenal allografts with exocrine

drainage into the bladder. Am J Surg Pathol 1990;14:837–846.

96. Atwell TD, Gorman B, Larson TS, et al. Pancreas transplants: experience with 232 percutaneous USguided biopsy procedures in 88 patients. Radiology 2004;231:845–849.

97. Kayler LK, Merion RM, Rudich SM, et al. Evaluation of pancreatic allograft dysfunction by

laparoscopic biopsy. Transplantation 2002;74:1287–1289.

98. Margreiter C, Aigner F, Resch T, et al. Enteroscopic biopsies in the management of pancreas

transplants: a proof of concept study for a novel monitoring tool. Transplantation 2012;93(2):207–

213.

99. Drachenberg CB, Torrealba JR, Nankivell BJ, et al. Guidelines for the diagnosis of antibodymediated rejection in pancreas allografts-updated Banff grading schema. Am J Transplant

2011;11(9):1792–1802.

100. Humar A, Khwaja K, Ramcharan T, et al. Chronic rejection: the next major challenge for pancreas

transplant recipients. Transplantation 2003;76:918–923.

1007

101. Waki K, Sugawara Y, Tamura S, et al. Simultaneous pancreas-kidney transplantation in the United

States: an analysis of the UNOS registry. Clin Transpl 2010;20:35–44.

102. Ringers J, van der Torren CR, van de Linde P, et al. Pretransplantation GAD-autoantibody status to

guide prophylactic antibody induction therapy in simultaneous pancreas and kidney transplantation.

Transplantation 2013;96(8):745–752.

103. Assalino M, Genevay M, Morel P, et al. Recurrence of type 1 diabetes after simultaneous pancreaskidney transplantation in the absence of GAD and IA-2 autoantibodies. Am J Transplant

2012;12(2):492–495.

104. Ricart MJ, Malaise J, Moreno AN, et al; Fernandez-Cruz L the Euro-SPK Study Group.

Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas–

kidney transplantation. Nephrol Dial Transplant 2005;20(suppl 2):ii25–ii32.

105. Axelrod D, Leventhal JR, Gallon LG, et al. Reduction of CMV disease with steroid-free

immunosuppresssion in simultaneous pancreas–kidney transplant recipients. Am J Transplant

2005;5:1423–1429.

106. Gupta G, Shapiro R, Thai N, et al. Low Incidence of BK virus nephropathy after simultaneous

kidney pancreas transplantation. Transplantation 2006;82:382–388.

107. Lipshutz GS, Mahanty H, Feng S, et al. BKV in simultaneous pancreas-kidney transplant recipients: a

leading cause of renal graft loss in first 2 years posttransplant. Am J Transplant 2005;5:366–373.

108. Paraskevas S, Coad JE, Gruessner A, et al. Posttransplant lymphoproliferative disorder in pancreas

transplantation: a single-center experience. Transplantation 2005;80:613–622.

109. Caillard S, Lamy FX, Quelen C, et al. French transplant centers. Epidemiology of posttransplant

lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French

registry and analysis of subgroups of lymphomas. Am J Transplant 2012;12(3):682–93.

110. Venstrom JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients

with diabetes and preserved kidney function. JAMA 2003;290:2817–2823.

111. Reddy KS, Stablein D, Taranto S, et al. Long-term survival following simultaneous kidney-pancreas

transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and

renal failure. Am J Kidney Dis 2003;41:464–470.

112. Kayler LK, Wen X, Zachariah M, et al. Outcomes and survival analysis of old-to-old simultaneous

pancreas and kidney transplantation. Transpl Int 2013;26(10):963–972.

113. Gruessner RWG, Sutherland DER, Gruessner AG. Mortality assessment for pancreas transplants. Am

J Transplant 2006;4(12):2018–2026.

114. Ojo AO, Meier-Kriesche HU, Hanson JA et al. The impact of simultaneous pancreas-kidney

transplantation on long-term patient survival. Transplantation 2001;71:82–90.

115. Sung RS, Zhang M, Schaubel DE, et al. A reassessment of the survival advantage of simultaneous

kidney-pancreas versus kidney-alone transplantation. Transplantation 2015;99(9):1900.

116. Bilous RW, Mauer SM, Sutherland DE, et al. The effects of pancreas transplantation on the

glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med

1989;321:80–85.

117. Fioretto P, Steffes MW, Sutherland DE, et al. Reversal of lesions of diabetic nephropathy after

pancreas transplantation. N Engl J Med 1998;339:69–75.

118. Khairoun M, de Koning EJ, van den Berg BM, et al. Microvascular damage in type 1 diabetic

patients is reversed in the first year after simultaneous pancreas-kidney transplantation. Am J

Transplant 2013;13(5):1272–1281.

119. Kennedy WR, Navarro X, Goetz FC, et al. Effects of pancreatic transplantation on diabetic

neuropathy. N Engl J Med 1990;322:1031–1037.

120. Tavakoli M, Mitu-Pretorian M, Petropoulos IN, et al. Corneal confocal microscopy detects early

nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation.

Diabetes 2013;62(1):254–260.

121. Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal conforcal microsopy detects early nerve

regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care

2007;30:2608–2612.

122. Kendall DM, Rooney DP, Smets YF, et al. Pancreas transplantation restores epinephrine response

and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and

1008

autonomic neuropathy. Diabetes 1997;46:249–257.

123. Walsh AW. Effects of pancreas transplantation on secondary complications of diabetes: retinopathy.

In: Gruessner RWG, Sutherland DER, eds. Transplantation of the Pancreas. New York, NY:Springer;

2004:462–470.

124. Giannarelli R, Coppelli A, Sartini MS, et al. Pancreas transplant alone has beneficial effects on

retinopathy in type 1 diabetic patients. Diabetologia 2006;49:2977–2982.

125. Boggi U, Vistoli F, Amorese G, et al. Long-term (5 years) efficacy and safety of pancreas

transplantation alone in type 1 diabetic patients. Transplantation 2012;93(8):842–846.